The Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in Schizophrenia
NACompletedINTERVENTIONAL
Enrollment
60
Participants
Timeline
Start Date
July 17, 2017
Primary Completion Date
September 21, 2018
Study Completion Date
September 21, 2018
Conditions
SchizophreniaInsight ImpairedPsychotic SymptomsSchizoaffective DisorderNeurocognitive DysfunctionAutonomic ImbalancePsychosocial ImpairmentQuality of Life
Interventions
DEVICE
tDCS
tDCS
Trial Locations (1)
114
Tri-service general hospital, Taipei
All Listed Sponsors
lead
Tri-Service General Hospital
OTHER
NCT03701100 - The Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in Schizophrenia | Biotech Hunter | Biotech Hunter